共 200 条
[2]
THE EORTC EARLY CLINICAL-TRIALS COOPERATIVE GROUP EXPERIENCE WITH 5-AZA-2'-DEOXYCYTIDINE (NSC-127716) IN PATIENTS WITH COLO-RECTAL, HEAD AND NECK, RENAL CARCINOMAS AND MALIGNANT MELANOMAS
[J].
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY,
1987, 23 (12)
:1921-1924
[3]
AHLUWALIA GS, 1986, CANCER RES, V46, P4479
[6]
ATTADIA V, 1993, LEUKEMIA, V7, P9
[7]
BAEHNER RL, 1984, CANCER TREAT REP, V68, P1269
[8]
IMPROVED REMISSION INDUCTION-RATE WITH D-ZAPO BUT UNIMPROVED REMISSION DURATION WITH ADDITION OF IMMUNOTHERAPY TO CHEMOTHERAPY IN PREVIOUSLY UNTREATED CHILDREN WITH ANLL
[J].
MEDICAL AND PEDIATRIC ONCOLOGY,
1979, 7 (02)
:127-139
[9]
BAILEY H, 1991, CANCER RES, V51, P1105